| Prathima Kishore, | |
|
6677 Richmond Hwy, Alexandria, VA 22306-6647 | |
| (703) 535-5568 | |
| (703) 535-1583 |
| Full Name | Prathima Kishore |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 6677 Richmond Hwy, Alexandria, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093109431 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 0710000580 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Prathima Kishore, 6677 Richmond Hwy, Alexandria, VA 22306-6647 Ph: (703) 535-5568 | Prathima Kishore, 6677 Richmond Hwy, Alexandria, VA 22306-6647 Ph: (703) 535-5568 |
News Archive
Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital.
Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed, has been developed by a team of engineers, physicians and radiologists led by the University of Cambridge.
Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial collaboration agreement with Merck, through a Merck subsidiary, to evaluate the safety and efficacy of Incyte's oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360, and Merck's investigational anti-PD-1 immunotherapy, MK-3475, in a Phase I/II study in previously treated metastatic and recurrent non-small cell lung cancer (NSCLC), and other advanced or metastatic cancers.
› Verified 1 days ago
Dr. John-paul James, PH.D., D.MIN., DACBN Counselor Medicare: Not Enrolled in Medicare Practice Location: 2800 Eisenhower Ave, Alexandria, VA 22314 Phone: 240-383-4800 Fax: 240-846-1533 | |
Mrs. Kasey Lynn Gordon Cain, RESIDENT INCOUNSELIG Counselor Medicare: Not Enrolled in Medicare Practice Location: 2850 Eisenhower Ave, Alexandria, VA 22314 Phone: 703-991-6005 | |
Amber Ferguson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2800 Eisenhower Ave Ste 200, Alexandria, VA 22314 Phone: 703-562-9220 Fax: 703-520-7745 | |
Qi Chen, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3361 Beechcliff Dr, Alexandria, VA 22306 Phone: 970-889-9295 | |
Karin Layne, QMHP, CASAC-S Counselor Medicare: Not Enrolled in Medicare Practice Location: 205 S Whiting St Ste 600, Alexandria, VA 22304 Phone: 571-257-8631 Fax: 571-231-4304 | |
Ms. Lynn Marie Fritts, Counselor Medicare: Not Enrolled in Medicare Practice Location: 720 N Saint Asaph St, Alexandria, VA 22314 Phone: 703-838-6400 Fax: 703-838-5062 | |
Lina Cuda, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 720 N Saint Asaph St, Alexandria, VA 22314 Phone: 703-746-3444 Fax: 703-746-3464 |